Biomaterial News: Breaking Biomaterial News, Comments and Articles. - Page: 4

MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals

KENNESAW, Ga., March 18, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that MiMedx management has received a number of inquiries regarding trading activity in its shares late last week and the resultant drop in...

MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference

KENNESAW, Ga., March 14, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTC: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Canaccord Genuity Musculoskeletal Conference in Chicago.  Parker H. "Pete" Petit, Chairman and CEO, William C. Tayl...

Global Regulatory Milestones for Invibio Biomaterial Solutions

Thornton-Cleveleys, UK (PRWEB) March 14, 2013 Invibio Biomaterial Solutions ' innovative PEEK-OPTIMA® family of biomaterials – including the world's first implantable grade polyetherketone (PEEK) polymer – have achieved c...

InVivo Therapeutics Reports 2012 Financial Results, Provides Business Update

InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported financial results for the year ended December 31, 2012 and provided a business update. InVivo has pioneered a new treatment platform utilizing a variety of bi...

Dr. Luciano Lanfranchi Opens Up a New Studio in the Heart of Milano

MILAN, March 12, 2013 /PRNewswire/ -- Luciano Lanfranchi, an internationally recognised plastic surgeon (chirurgoplastico Milano) with base in Milano announces his expansion. Born and raised in Argentina in 1975, Luciano moved to Milano in the year 2000 to take a degree in Medicine and Surgery at the University of Milano. After finishing his degree he decided to permanently relocate in order to...

How Insect Wings Destroy Bacteria

In a new study, researchers describe how the veined wing of the Clanger cicada is the first known example of a natural biomaterial that kills bacteria on contact, using only its physical structure, unaided by chemical or biological agents. Tiny nano...

RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in ...

Jerusalem, Israel, March 12, 2013 / B3C newswire / -RegeneCure announced today the successful results of a clinical study in pets using the company's regenerative membrane implant technology for the treatment of bone fractures. The study showed that the healing time was about 40 percent quicker than normally observed using current Standard of Care therapies. The product was also demonstrated to b...

Oral Care Products & Dental Consumables Market to Reach $17.46 Billion by 2016 - New Report by MarketsandMarkets

(PRWEB) March 10, 2013 The “Oral Care Products & Other Dental Consumables Market (Dental Biomaterials, Specialty Products, & Restoratives) Current Trends, Opportunities & Global Forecasts to 2016” analyzes and studies the maj...

X-STATIC® Antimicrobial Technology Launches Webinar Available For CE Credit

SCRANTON, Pa., March 8, 2013 /PRNewswire/ -- Just in time for National Patient Safety Awareness Week, X-STATIC® Antimicrobial Technology launched a new webinar available for CE credit: "A More Complete Approach to Infection Prevention: Bacterial Management of Soft Surfaces and Associated Reduction in HAIs."  Webinar leader, Peggy Prinz Luebbert, highlights the importance of soft surface...

MiMedx Announces 2012 Results

KENNESAW, Ga., March 7, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the year ended December 31, 2012. Highlights of 2012 Results include: Tripling of Revenue over 2011 First full year of p...

Interface Biologics' CSO Paul Santerre receives NSERC Synergy Innovation Award from Governor General

TORONTO, ONTARIO -- (Marketwire) -- 03/05/13 -- Editors Note: There is a photo associated with this press release. Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that Dr. Paul Santerre, PhD, Chief Scientific Officer at IBI, was presented with a Synergy Award for Innovation by His Excellency the Rig...

How Gold Particles, DNA And Water Have The Potential To Shape The Future Of Medicine

A diagnostic "cocktail" containing a single drop of blood, a dribble of water, and a dose of DNA powder with gold particles could mean rapid diagnosis and treatment of the world's leading diseases in the near future. The cocktail diagnostic is a home...

InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced the Company has submitted an updated Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) requesting permission to begin human studies in ord...

Pour, shake and stir

(University of Toronto Faculty of Applied Science & Engineering) A diagnostic "cocktail" containing a single drop of blood, a dribble of water, and a dose of DNA powder with gold particles could mean rapid diagnosis and treatment of the world's leadi...

Josep Anton Planell nominated to take over as the new president of the UOC

Dr. Planell is currently director of the Institute of Bioengineering of Catalonia (IBEC) and has spent much of his career in the research of biomaterials.

Ventrix presents pre-clinical study results of VentriGel cardiac repair scaffold

Ventrix said that its VentriGel biomaterial scaffold has shown potential to prevent heart failure following heart attack in a pre-clinical study.

Researchers Implant Ultrathin Nanowires To Receive First Signals From Brain Nerve Cells

Electrodes inserted into the brain are today used in research and to treat diseases such as Parkinson's. However, their use has been limited by their size. At Lund University in Sweden, researchers have, for the first time, succeeded in implanting an...

Hip implant failure rates higher in women

Hip implant failure is more likely to occur among women, according to a new study of over 35,000 patients in the US.According to research published in the Journal of the American Medical Association (JAMA) Internal Medicine, by a team from the Southern California Permanente Medical Group in the US, women are 29 per cent more likely than men to need repeat surgery within three years of receiving a...

Ventrix's VentriGel™ Demonstrates Potential to Prevent Heart Failure Following Heart Attack

SAN DIEGO, Feb. 20, 2013 /PRNewswire/ -- Ventrix, Inc. announced today that its VentriGel™ cardiac repair scaffold safely and effectively mitigated left ventricular remodeling and improved cardiac function in pigs after myocardial infarction, or heart attack. The findings, made during pre-clinical studies, were published today in the journal Science Translational Medicine. Based on these and...

A screening approach reveals the influence of mineral coating morphology on human mesenchymal stem cell differentiation

“Biomimetic” inorganic coating on biomaterials has been an active area of research with the intention of providing bioactive surfaces that can regulate cell behavior. Previous studies have demonstrated that human mesenchymal stem cell (hMSC) beha...

Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Feb. 20, 2013 /PRNewswire/ -- New wound care technologies that detect early wound healing and manage wound healing mechanisms are finding favor with physicians that are trying to determine suitable treatment protocols. Wound care management received a thrust from cost-effective and efficient technologically advanced products and therapies. Some wound care advan...

Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif. , Feb. 20, 2013 /- New wound care technologies that detect early wound healing and manage wound healing mechanisms are finding favor with physicians that are trying to determine suitable treatment protocols. Wound care man...

CCRM Introduces CGP-led Ethics Unit to Promote Responsible Research

TORONTO, ONTARIO and MONTREAL, QUEBEC -- (Marketwire) -- 02/20/13 -- In an effort to address ethical, legal and social issues (ELSI) as part of its activities to develop new regenerative medicine (RM) products for, and with, academia and industry that will fill specific gaps in the product development pathway, the Centre for Commercialization of Regenerative Medicine (CCRM) is adding an ethics un...

Using mussel adhesive proteins for medical applications

When it comes to adhesive power under wet conditions, nothing beats marine mussels. They can stick to virtually all surfaces, creating and sustaining their tenacious bonds while fully submerged. Northwestern University’s Phillip B. Messersmith has...

Designer Blood Clots Could Help Injured Soldiers On The Battlefield

When it comes to healing the terrible wounds of war, success may hinge on the first blood clot - the one that begins forming on the battlefield right after an injury. Researchers exploring the complex stream of cellular signals produced by the body i...